A two-component nanoparticle system that communicates and enhances in vivo drug delivery and diagnostics has been devised. The system comprises ‘signalling’ nanoparticles that target tumours and then broadcast the tumour’s location to ’receiving’ nanoparticles in circulation, which carry therapeutic or diagnostic cargos, hence amplifying tumour targeting.
- Geoffrey von Maltzahn
- Ji-Ho Park
- Sangeeta N. Bhatia
